TG Therapeutics, Inc. SEC filings TGTX
TG Therapeutics, Inc. has 1,000 filings in SEC EDGAR's recent list, going back to Feb 28, 2003. Its latest annual report, Form 10-K, was filed on Feb 27, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 5, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Aug 3, 2026 (results of operations). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| 10-Q | Quarterly report | Aug 5, 2026 | Jun 30, 2026 |
| 8-K |
Current report
Results of operations
|
Aug 3, 2026 | Aug 3, 2026 |
| 8-K |
Current report
Shareholder vote results
|
Jun 12, 2026 | Jun 11, 2026 |
| 8-K |
Current report
Other events
|
Jun 3, 2026 | Jun 3, 2026 |
| 8-K |
Current report
Other events
|
May 27, 2026 | May 27, 2026 |
| 10-Q | Quarterly report | May 6, 2026 | Mar 31, 2026 |
| 8-K |
Current report
Results of operations
|
May 6, 2026 | May 6, 2026 |
| DEF 14A | Proxy statement | Apr 30, 2026 | Jun 11, 2026 |
| 8-K |
Current report
Material agreement, New debt
|
Mar 20, 2026 | Mar 18, 2026 |
| 10-K | Annual report | Feb 27, 2026 | Dec 31, 2025 |
| 8-K |
Current report
Results of operations
|
Feb 26, 2026 | Feb 26, 2026 |
| 8-K |
Current report
Regulation FD disclosure
|
Jan 13, 2026 | Jan 13, 2026 |
| 10-Q | Quarterly report | Nov 5, 2025 | Sep 30, 2025 |
| 8-K |
Current report
Results of operations
|
Nov 3, 2025 | Nov 3, 2025 |
| S-8 | Employee stock plan registration | Aug 8, 2025 | — |
| S-3ASR | Automatic shelf registration | Aug 8, 2025 | — |
| 10-Q | Quarterly report | Aug 8, 2025 | Jun 30, 2025 |
| 8-K |
Current report
Results of operations
|
Aug 4, 2025 | Aug 4, 2025 |
| 8-K |
Current report
Shareholder vote results
|
Jun 13, 2025 | Jun 12, 2025 |
| 10-Q | Quarterly report | May 9, 2025 | Mar 31, 2025 |
| 8-K |
Current report
Results of operations
|
May 5, 2025 | May 5, 2025 |
| ARS | Annual report to shareholders | Apr 30, 2025 | Dec 31, 2024 |
| DEFA14A | Additional proxy material | Apr 30, 2025 | — |
| DEF 14A | Proxy statement | Apr 30, 2025 | Jun 12, 2025 |
| PRE 14A | Preliminary proxy statement | Apr 18, 2025 | Jun 12, 2025 |
| 10-K | Annual report | Mar 3, 2025 | Dec 31, 2024 |
| 8-K |
Current report
Results of operations
|
Mar 3, 2025 | Mar 3, 2025 |
| 8-K |
Current report
Regulation FD disclosure
|
Jan 14, 2025 | Jan 14, 2025 |
| 10-Q | Quarterly report | Nov 7, 2024 | Sep 30, 2024 |
| 8-K |
Current report
Results of operations
|
Nov 4, 2024 | Nov 4, 2024 |
| 10-Q | Quarterly report | Aug 9, 2024 | Jun 30, 2024 |
| 10-K/A | Amended annual report | Aug 9, 2024 | Dec 31, 2023 |
| 8-K |
Current report
Material agreement, Agreement ended, Results of operations, Other events
|
Aug 6, 2024 | Aug 2, 2024 |
| 8-K |
Current report
Officer or director change, Bylaw or fiscal year change, Shareholder vote results
|
Jun 17, 2024 | Jun 14, 2024 |
| PX14A6G | Filing | Jun 13, 2024 | — |
| PX14A6G | Calstrs form px14a6g | Jun 10, 2024 | — |
| 10-Q | Quarterly report | May 6, 2024 | Mar 31, 2024 |
| 8-K |
Current report
Results of operations
|
May 1, 2024 | May 1, 2024 |
| ARS | Annual report to shareholders | Apr 29, 2024 | Dec 31, 2023 |
| DEFA14A | Additional proxy material | Apr 29, 2024 | — |
| DEF 14A | Proxy statement | Apr 29, 2024 | Jun 14, 2024 |
| PRE 14A | Preliminary proxy statement | Apr 18, 2024 | Jun 4, 2024 |
| 10-K | Annual report | Feb 29, 2024 | Dec 31, 2023 |
| 8-K |
Current report
Results of operations
|
Feb 28, 2024 | Feb 28, 2024 |
| 8-K |
Current report
Material agreement, Regulation FD disclosure
|
Jan 10, 2024 | Jan 7, 2024 |
| 10-Q | Quarterly report | Nov 6, 2023 | Sep 30, 2023 |
| 8-K |
Current report
Results of operations
|
Nov 1, 2023 | Nov 1, 2023 |
| 10-Q | Quarterly report | Aug 4, 2023 | Jun 30, 2023 |
| 8-K |
Current report
Material agreement, Results of operations
|
Aug 1, 2023 | Jul 28, 2023 |
| 8-K |
Current report
Shareholder vote results
|
Jun 15, 2023 | Jun 14, 2023 |
| 10-Q | Quarterly report | May 8, 2023 | Mar 31, 2023 |
| DEFA14A | Additional proxy material | May 1, 2023 | — |
| DEF 14A | Proxy statement | May 1, 2023 | — |
| 8-K |
Current report
Results of operations
|
May 1, 2023 | May 1, 2023 |
| PRE 14A | Preliminary proxy statement | Apr 21, 2023 | — |
| 10-K | Annual report | Mar 1, 2023 | Dec 31, 2022 |
| 8-K |
Current report
Results of operations
|
Feb 28, 2023 | Feb 28, 2023 |
| 8-K |
Current report
Other events
|
Dec 28, 2022 | Dec 28, 2022 |
| 8-K |
Current report
Results of operations
|
Nov 10, 2022 | Nov 10, 2022 |
| 10-Q | Quarterly report | Nov 9, 2022 | Sep 30, 2022 |
| S-3ASR | Automatic shelf registration | Sep 2, 2022 | — |
| 10-Q | Quarterly report | Aug 9, 2022 | Jun 30, 2022 |
| 8-K |
Current report
Results of operations
|
Aug 8, 2022 | Aug 8, 2022 |
| S-8 | Employee stock plan registration | Jun 24, 2022 | — |
| 8-K |
Current report
Shareholder vote results
|
Jun 23, 2022 | Jun 16, 2022 |
| 10-Q | Quarterly report | May 10, 2022 | Mar 31, 2022 |
| DEFA14A | Additional proxy material | Apr 29, 2022 | — |
| DEF 14A | Proxy statement | Apr 29, 2022 | Jun 16, 2022 |
| 8-K |
Current report
Other events
|
Apr 18, 2022 | Apr 15, 2022 |
| 10-K | Annual report | Mar 1, 2022 | Dec 31, 2021 |
| 8-K |
Current report
Results of operations
|
Mar 1, 2022 | Mar 1, 2022 |
| 8-K |
Current report
Other events
|
Jan 27, 2022 | Jan 27, 2022 |
| 8-K |
Current report
Material agreement
|
Jan 4, 2022 | Dec 30, 2021 |
| 8-K |
Current report
Other events
|
Nov 30, 2021 | Nov 30, 2021 |
| 10-Q | Quarterly report | Nov 8, 2021 | Sep 30, 2021 |
| 8-K |
Current report
Results of operations
|
Nov 4, 2021 | Nov 4, 2021 |
| 10-Q | Quarterly report | Aug 6, 2021 | Jun 30, 2021 |
| 8-K |
Current report
Results of operations
|
Aug 2, 2021 | Aug 2, 2021 |
| 8-K |
Current report
Officer or director change
|
Jun 23, 2021 | Jun 18, 2021 |
| 8-K |
Current report
Bylaw or fiscal year change, Shareholder vote results
|
Jun 21, 2021 | Jun 16, 2021 |
| 10-Q | Quarterly report | May 10, 2021 | Mar 31, 2021 |
| 8-K |
Current report
Results of operations
|
May 10, 2021 | May 10, 2021 |
| DEFA14A | Additional proxy material | Apr 30, 2021 | — |
| DEF 14A | Proxy statement | Apr 30, 2021 | Jun 16, 2021 |
| PRE 14A | Preliminary proxy statement | Apr 20, 2021 | Jun 16, 2021 |
| 8-K |
Current report
Other events
|
Apr 16, 2021 | Apr 16, 2021 |
| 8-K |
Current report
Auditor change
|
Apr 13, 2021 | Apr 12, 2021 |
| 8-K |
Current report
Results of operations
|
Mar 2, 2021 | Mar 2, 2021 |
| 10-K | Annual report | Mar 1, 2021 | Dec 31, 2020 |
| 8-K |
Current report
Other events
|
Feb 8, 2021 | Feb 5, 2021 |
| 8-K |
Current report
Material agreement
|
Dec 16, 2020 | Dec 14, 2020 |
| 424B5 | Prospectus supplement | Dec 16, 2020 | — |
| 424B5 | Prospectus supplement | Dec 14, 2020 | — |
| 8-K |
Current report
Other events
|
Dec 10, 2020 | Dec 10, 2020 |
| 8-K |
Current report
Other events
|
Dec 8, 2020 | Dec 7, 2020 |
| 8-K |
Current report
Results of operations
|
Nov 9, 2020 | Nov 9, 2020 |
| 8-K |
Current report
Other events
|
Nov 9, 2020 | Nov 9, 2020 |
| 424B5 | Prospectus supplement | Nov 9, 2020 | — |
| 10-Q | Quarterly report | Nov 9, 2020 | Sep 30, 2020 |
| 8-K |
Current report
Other events
|
Nov 5, 2020 | Nov 4, 2020 |
| 10-Q | Quarterly report | Aug 10, 2020 | Jun 30, 2020 |
| 8-K |
Current report
Results of operations
|
Aug 10, 2020 | Aug 10, 2020 |
| 8-K |
Current report
Officer or director change, Shareholder vote results
|
Jun 24, 2020 | Jun 18, 2020 |
| PX14A6G | Filing | May 29, 2020 | — |
| 8-K |
Current report
Material agreement
|
May 18, 2020 | May 14, 2020 |
| 424B5 | Prospectus supplement | May 18, 2020 | — |
| 424B5 | Prospectus supplement | May 14, 2020 | — |
| 8-K |
Current report
Results of operations
|
May 11, 2020 | May 11, 2020 |
| 10-Q | Quarterly report | May 11, 2020 | Mar 31, 2020 |
| 8-K |
Current report
Other events
|
May 5, 2020 | May 5, 2020 |
| 8-K |
Current report
Officer or director change
|
Apr 30, 2020 | Apr 24, 2020 |
| DEFA14A | Additional proxy material | Apr 29, 2020 | — |
| DEF 14A | Proxy statement | Apr 29, 2020 | Jun 18, 2020 |
| 424B5 | Prospectus supplement | Mar 20, 2020 | — |
| 8-K |
Current report
Other events
|
Mar 20, 2020 | Mar 20, 2020 |
| 8-K |
Current report
Results of operations
|
Mar 3, 2020 | Mar 3, 2020 |
| 10-K | Annual report | Mar 2, 2020 | Dec 31, 2019 |
| 8-K |
Current report
Other events
|
Dec 26, 2019 | Dec 22, 2019 |
| 424B5 | Prospectus supplement | Dec 23, 2019 | — |
| 8-K |
Current report
Other events
|
Dec 9, 2019 | Dec 8, 2019 |
| 10-Q | Quarterly report | Nov 12, 2019 | Sep 30, 2019 |
| 8-K |
Current report
Results of operations
|
Nov 12, 2019 | Nov 12, 2019 |
| 8-K |
Current report
Other events
|
Oct 28, 2019 | Oct 28, 2019 |
| 8-K |
Current report
Other events
|
Sep 12, 2019 | Sep 12, 2019 |
| S-3ASR | Automatic shelf registration | Sep 5, 2019 | — |
| RW | Form rw | Sep 5, 2019 | — |
| S-3 | Shelf registration | Aug 30, 2019 | — |
| 10-Q | Quarterly report | Aug 9, 2019 | Jun 30, 2019 |
| 8-K |
Current report
Results of operations
|
Aug 9, 2019 | Aug 9, 2019 |
| 8-K |
Current report
Shareholder vote results
|
Jun 13, 2019 | Jun 13, 2019 |
| PX14A6G | Filing | May 31, 2019 | — |
| 10-Q | Quarterly report | May 10, 2019 | May 10, 2019 |
| 8-K |
Current report
Results of operations
|
May 10, 2019 | May 10, 2019 |
| 8-K |
Current report
Other events
|
May 8, 2019 | May 7, 2019 |
| DEFA14A | Additional proxy material | Apr 30, 2019 | — |
| DEF 14A | Proxy statement | Apr 30, 2019 | Jun 13, 2019 |
| 8-K |
Current report
Other events
|
Apr 1, 2019 | Apr 1, 2019 |
| 424B5 | Prospectus supplement | Mar 5, 2019 | — |
| 8-K |
Current report
Material agreement, Other events
|
Mar 5, 2019 | Feb 28, 2019 |
| 10-K | Annual report | Mar 1, 2019 | Dec 31, 2018 |
| 424B5 | Prospectus supplement | Feb 28, 2019 | — |
| 8-K |
Current report
Other events
|
Feb 28, 2019 | Feb 28, 2019 |
| 8-K |
Current report
Other events
|
Jan 22, 2019 | Jan 22, 2019 |
| 8-K |
Current report
Other events
|
Dec 4, 2018 | Dec 3, 2018 |
| 10-Q | Quarterly report | Nov 9, 2018 | Sep 30, 2018 |
| 8-K |
Current report
Results of operations
|
Nov 9, 2018 | Nov 8, 2018 |
| 8-K |
Current report
Other events
|
Oct 15, 2018 | Oct 11, 2018 |
| 8-K |
Current report
Other events
|
Sep 25, 2018 | Sep 25, 2018 |
| CT ORDER | Filing | Sep 18, 2018 | — |
| 10-Q | Quarterly report | Aug 9, 2018 | Jun 30, 2018 |
| 8-K |
Current report
Results of operations
|
Aug 7, 2018 | Jun 30, 2018 |
| EFFECT | Filing | Jul 23, 2018 | — |
| CORRESP | Letter to the SEC | Jul 18, 2018 | — |
| UPLOAD | Letter from the SEC | Jul 17, 2018 | — |
| S-3 | Shelf registration | Jul 9, 2018 | — |
| S-8 | Employee stock plan registration | Jun 25, 2018 | — |
| 8-K |
Current report
Material agreement
|
Jun 20, 2018 | Jun 18, 2018 |
| 8-K |
Current report
Other events
|
Jun 18, 2018 | Jun 18, 2018 |
| 8-K |
Current report
Other events
|
Jun 15, 2018 | Jun 15, 2018 |
| 8-K |
Current report
Shareholder vote results
|
Jun 13, 2018 | Jun 13, 2018 |
| 8-K |
Current report
Other events
|
Jun 7, 2018 | Jun 7, 2018 |
| 8-K |
Current report
Other events
|
Jun 4, 2018 | Jun 4, 2018 |
| 10-Q | Quarterly report | May 10, 2018 | Mar 31, 2018 |
| 8-K |
Current report
Results of operations
|
May 8, 2018 | Mar 31, 2018 |
| CT ORDER | Filing | Apr 30, 2018 | — |
| DEFA14A | Additional proxy material | Apr 30, 2018 | — |
| DEF 14A | Proxy statement | Apr 30, 2018 | Jun 13, 2018 |
| 8-K |
Current report
Other events
|
Apr 24, 2018 | Apr 24, 2018 |
| 10-K | Annual report | Mar 15, 2018 | Dec 31, 2017 |
| 8-K |
Current report
Results of operations
|
Mar 8, 2018 | Mar 8, 2018 |
| 8-K |
Current report
Other events
|
Feb 2, 2018 | Feb 2, 2018 |
| 8-K |
Current report
Material agreement
|
Jan 8, 2018 | Jan 8, 2018 |
| 8-K |
Current report
Other events
|
Dec 11, 2017 | Dec 11, 2017 |
| 10-Q | Quarterly report | Nov 9, 2017 | Sep 30, 2017 |
| 8-K |
Current report
Results of operations
|
Nov 8, 2017 | Nov 8, 2017 |
| 8-K |
Current report
Other events
|
Oct 27, 2017 | Oct 26, 2017 |
| 8-K |
Current report
Other events
|
Oct 17, 2017 | Oct 16, 2017 |
| 8-K |
Current report
Other events
|
Sep 5, 2017 | Sep 5, 2017 |
| 8-K |
Current report
Other events
|
Aug 10, 2017 | Aug 10, 2017 |
| 10-Q | Quarterly report | Aug 9, 2017 | Jun 30, 2017 |
| 8-K |
Current report
Results of operations
|
Aug 9, 2017 | Aug 9, 2017 |
| 8-K |
Current report
Other events
|
Aug 1, 2017 | Aug 1, 2017 |
| 8-K |
Current report
Shareholder vote results
|
Jun 21, 2017 | Jun 16, 2017 |
| 8-K |
Current report
Other events
|
Jun 16, 2017 | Jun 14, 2017 |
| EFFECT | Filing | Jun 13, 2017 | — |
| CORRESP | Letter to the SEC | Jun 9, 2017 | — |
| S-3/A | S-3 | Jun 9, 2017 | — |
| 8-K |
Current report
Other events
|
Jun 5, 2017 | Jun 5, 2017 |
| S-3 | Shelf registration | May 26, 2017 | — |
| 8-K |
Current report
Other events
|
May 24, 2017 | May 23, 2017 |
| 10-Q | Quarterly report | May 10, 2017 | Mar 31, 2017 |
| 8-K |
Current report
Results of operations
|
May 5, 2017 | May 5, 2017 |
| 8-K |
Current report
Other events
|
May 1, 2017 | Apr 28, 2017 |
| DEF 14A | Proxy statement | Apr 28, 2017 | Jun 16, 2017 |
| 10-K/A | Amended annual report | Mar 21, 2017 | Dec 31, 2016 |
| 10-K | Annual report | Mar 16, 2017 | Dec 31, 2016 |
| 424B5 | Prospectus supplement | Mar 10, 2017 | — |
| 8-K |
Current report
Other events
|
Mar 10, 2017 | Mar 10, 2017 |
| 8-K |
Current report
Material agreement, Other events
|
Mar 9, 2017 | Mar 9, 2017 |
| 424B5 | Prospectus supplement | Mar 8, 2017 | — |
Showing 200 filings, the most recent 200. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- TGTX (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- New York, NY
- SEC filer status
- Large accelerated filer
- SEC CIK
- 1001316
- Former names
- MANHATTAN PHARMACEUTICALS INC (until Apr 27, 2012); ATLANTIC TECHNOLOGY VENTURES INC (until Mar 10, 2003); ATLANTIC PHARMACEUTICALS INC (until Feb 4, 2000)
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.